Boothbay Fund Management’s Compass Therapeutics CMPX Stock Holding History

Boothbay Fund Management’s Portfolio CMPX Stock Details CMPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-205,024	Closed	-$1.1M	–	2125
2025 Q4	$1.1M	Buy	+205,024	New	+$947K	0.03%	766
2025 Q2	–	Hold	0	–	–	–	1513
2025 Q1	–	Hold	0	–	–	–	1473
2023 Q2	–	Sell	-26,945	Closed	-$88.1K	–	1903
2023 Q1	$88.1K	Buy	26,945 +9,815	+57%	+$38.5K	﹤0.01%	1967
2022 Q4	$86.2K	Buy	+17,130	New	+$68.3K	﹤0.01%	1827

Other funds holding CMPX

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM